Prominent publications by Anna Thorisdottir
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
[ PUBLICATION ]
BACKGROUND: The prevalence and severity of lipodystrophy syndrome with long-term therapy for HIV-1 infection that includes a protease inhibitor is unknown. We studied the natural course of the syndrome to develop diagnostic criteria and identifying markers that predict its severity.
METHODS: We assessed 113 patients who were receiving HIV-1 protease inhibitors (mean 21 months) and 45 HIV-1-infected patients (28 with follow-up) never treated with a protease inhibitor. Lipodystrophy was ...
|Also Ranks for: Diabetes Mellitus | physical examination | protease inhibitor | prevalence severity | therapy hiv1|
Key People For Prevalence Severity
Anna Thorisdottir:Expert Impact
Concepts for whichAnna Thorisdottirhas direct influence:Prevalence severity, Protease inhibitor, Lipodystrophy severity, Inhibitor therapy, Severity lipodystrophy, Inhibitor lipodystrophy, Hiv1 infection, Hiv1 protease inhibitors.
Anna Thorisdottir:KOL impact
Concepts related to the work of other authors for whichfor which Anna Thorisdottir has influence:Antiretroviral therapy, Hiv infection, Insulin resistance, Protease inhibitors, Human immunodeficiency virus, Infected patients, Highly active.
Is this your profile? Claim your profile Copy URL Embed Link to your profile